==== Front Am J Case RepAm J Case RepamjcaserepThe American Journal of Case Reports1941-5923International Scientific Literature, Inc. 3006890010.12659/AJCR.909325909325ArticlesCat-Scratch Disease in an AIDS Patient Presenting with Generalized Lymphadenopathy: An Unusual Presentation with Delayed Diagnosis Mantis Jazila ADEF1Ali Yasir ADEF2Junejo Shoaib Zahoor AEF2 1 Division of Infectious Disease, Icahn School of Medicine at Mount Sinai, NYC Health + Hospital/Queens, New York, NY, U.S.A. 2 Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, NYC Health + Hospital/Queens, New York, NY, U.S.A.Authors’ Contribution: A Study Design B Data Collection C Statistical Analysis D Data Interpretation E Manuscript Preparation F Literature Search G Funds Collection Conflict of interest: None declared Corresponding Author: Jazila Mantis, e-mail: mantisj@nychhc.org2018 02 8 2018 19 906 911 02 2 2018 24 4 2018 © Am J Case Rep, 20182018This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)Patient: Female, 44 Final Diagnosis: Cat-scratch disease Symptoms: Lymfadenopathy Medication: — Clinical Procedure: Lymph node biopsy Specialty: Infectious Diseases Objective: Unusual clinical course Background: Bartonella infection is the causative organism of cat-scratch disease (CSD), which typically presents with self-limited localized lymphadenopathy. In HIV-infected patients, Bartonella infection can cause systemic illnesses with significant morbidity and mortality manifesting as bacillary angiomatosis (BA), hepatic peliosis, splenitis, bacteremic febrile illness, and other organ involvement. To the best of our knowledge, there have been no reports of HIV-infected patients presenting with generalized lymphadenopathy caused by Bartonella infection. We report an unusual case of CSD presenting with generalized lymphadenopathy in an AIDS patient with advanced immunosuppression. Case Report: A 44-year-old woman with AIDS, advanced immunosuppression, and intermittent adherence to antiretroviral therapy and medical care, presented with cough and increased generalized tender lymphadenopathy. A lymph node biopsy 1 year earlier was non-diagnostic for tuberculosis, fungal infection, and lymphoproliferative disorders. She remained with generalized lymphadenopathy. A repeat biopsy with the addition of Warthin-Starry silver staining suggested the diagnosis of cat-scratch lymphadenitis. She responded well to a long course of azithromycin antibiotic therapy, with the resolution of lymphadenopathy. Conclusions: Cat-scratch disease may present with prolonged generalized lymphadenopathy, an unusual presentation in HIV patients with advanced immunosuppression. Awareness of the possibility of CSD in a similar clinical scenario may prompt early recognition and management of this disease. MeSH Keywords: Angiomatosis, BacillaryCat-Scratch DiseaseHIV InfectionsLymphadenitis ==== Body Background Cat-scratch disease (CSD) is an illness caused by Bartonella henselae infection following cat exposure, usually a cat-scratch or bite, most commonly occurring in children and young adults; with the median age of 21 years [1,2]. Typical CSD in immunocompetent patients presents as a regional lymphadenopathy accompanied by fever and other systemic symptoms of malaise, fatigue, and night sweats and is usually benign and self-limited. About 10% of patients have atypical CSD, mainly in older adults with manifestations including Parinaud oculo-glandular syndrome, neuroretinitis, granulomatous hepatitis, erythema nodosum, and, rarely, endocarditis, osteomyelitis, myalgias, and arthropathy [3,4]. Bartonella infections caused by B. henselae or B. quintana in immunocompromised patients primarily present as a systemic illness that may be characterized by angioproliferative lesions involving the skin, liver, and spleen. Bacillary angiomatosis (BA) lesions and fever are the most common manifestations of B. henselae and B. quintana in HIV/AIDS patients [5], with clinical manifestations, including cutaneous vascular lesions, subcutaneous nodules, and vascular-proliferative disease, affecting the liver and spleen, and systemic illness with fever, bacteremia, and weight loss [6,7]. Isolation of Bartonella bacteria from blood and tissue is difficult, requiring prolonged incubation. The organisms can be seen on Warthin-Starry staining of histopathologic specimens, and PCR assay can be used in detecting Bartonella DNA in tissue [8,9]. We report a case of prolonged generalized lymphadenopathy of more than 1-year duration in an AIDS patient on intermittent antiretroviral therapy (ART) and Mycobacterium avium complex (MAC) prophylaxis. Case Report A 44-year-old woman was admitted with a few days’ history of cough, whitish sputum production, and acute increase in painful, enlarged neck lymph nodes. She was diagnosed with AIDS 7 years earlier and had previously been treated for oral thrush, genital herpes simplex infection, syphilis, and recurrent episodes of Pneumocystis jirovecii pneumonia (PCP). She received ART with a combination of rilpivirine/emtricitabine/tenofovir and raltegravir in addition to trimethoprim sulfamethoxazole and weekly azithromycin for PCP and MAC prophylaxis, respectively. She reported intermittent adherence to her medications and medical care. She reported stopping her ART and PCP prophylaxis 2 months prior to admission and then resuming her medications 6 weeks later. One year earlier, she was evaluated at a different facility for enlarged lymph nodes and underwent right epitrochlear lymph node biopsy that revealed non-necrotizing granuloma with negative fungal and mycobacterial stains and cultures. She remained with generalized lymphadenopathy with occasional febrile episodes and unquantified weight loss. On presentation, she was afebrile. Results of a physical exam were significant for diffusely enlarged and tender anterior and posterior cervical lymphadenopathy, and bilateral epitrochlear, axillary, and inguinal lymphadenopathy. Laboratory findings were significant for a CD4 count of 77 (4%), HIV viral load 1370 copies/ml, and elevated LDH 450U/L. The result of a TB QuantiFERON test was negative. A chest x-ray was suggestive of hilar and subcarinal adenopathy (Figure 1A, 1B). A computed tomography (CT) scan of the neck and chest showed extensive cervical lymphadenopathy, nodes in the suboccipital region on the left, supraclavicular, axillary, subpectoral, paratracheal, and hilar lymphadenopathy, as well as celiac adenopathy in the visualized portion of the upper abdomen (Figure 2). The largest nodal mass in the subcarinal region measured 4×2.6 cm (Figures 3A–3C). The patient received a 5-day course of azithromycin for bronchitis and an outpatient lymph node biopsy was scheduled for 2 weeks later. At the time of biopsy, she felt clinically improved, with decrease in cervical adenopathy and tenderness. A cervical lymph node biopsy showed necrotizing granuloma with palisaded epithelioid cells, partially preserved nodular pattern, thickened capsule, and vascular proliferation. Warthin-Starry staining revealed clumps of pleomorphic bacilli, consistent with Bartonella species, favoring cat-scratch lymphadenitis. She reported having a 2-year-old pet cat at home. She was started on a 12-week course of oral azithromycin 600 mg daily. One week after starting the antibiotic course, a repeat chest CT and an abdomen CT revealed significantly decreased bilateral axillary, hilar, and mediastinal adenopathy (Figure 4). The dominant nodal mass in the subcarinal region measured 1.9 cm compared to 4 cm on the previous CT exam. There was extensive adenopathy in the region of the celiac axis, superior mesenteric artery and small bowel mesentery (Figure 5). She continued to improve clinically, with resolution of cervical, axillary, epitrochlear, and inguinal adenopathy. A planned repeat CT of chest and abdomen at the end of the 12-week azithromycin course was not done as the patient was lost to follow-up. Discussion Cat-scratch disease (CSD) is usually caused by Bartonella henselae [10–12] and cats are the main reservoir for the organism. The disease is linked to cat or flea exposure and in immunocompetent human hosts it is typically a local infection that manifests as cutaneous lesions at the site of inoculation and tender regional lymphadenopathy [13]. Localized disease is generally a self-limited illness. Generalized lymphadenopathy is rare. In a review of 1200 patients with CSD by Carithers, all patients in the series had lymphadenopathy; 85% had single-node involvement and the remainder had regional lymph node involvement, usually with only 2, occasionally 3, and rarely 4 or more nodes enlarged. None of the patients in this series had generalized lymphadenopathy [14]. In some individuals, CSD can include visceral organ involvement, an important manifestation in children, mainly the affecting the liver and spleen [15–17]. The diagnosis of CSD is often made presumptively based on characteristic clinical features and a history of recent cat or flea contact. Treatment, when indicated, is typically a 5-day course of azithromycin [18]. Bartonella infections in HIV-infected patients can cause serious morbidity and mortality, especially in those with significant immunosuppression [19]. Two species cause clinical infections in HIV-infected patients: Bartonella henselae, usually in patients who have a history of cat exposure, and Bartonella quintana, usually in homeless individuals with body lice. The clinical manifestations include BA, lesions involving the liver (hepatic peliosis) [20], splenitis, osteomyelitis, bacteremia, subcutaneous masses, and hemophagocytic lymphohistiocytosis [21,22]. BA is a common presentation in HIV-infected individuals with advanced immunosuppression, characterized by violaceous, friable, and vascular lesions that bleed profusely with trauma. These lesions most frequently involve the skin but can also involve internal organs, including the liver and spleen [23]. Constitutional symptoms are reported by almost all patients with BA. Definitive diagnosis can be challenging since Bartonella species generally do not grow in routine cultures and isolation of the fastidious, slow-growing, gram-negative organism is difficult, requiring extended incubation with specific growth conditions [24]. The sensitivity of culture for Bartonella henselae from blood or lymph nodes has been reported to be as low as 20% [8]. Detection of Bartonella DNA in tissue specimens via polymerase chain reaction (PCR) assay is diagnostic, but the sensitivity is very low, especially when the duration of illness is more than 6 weeks [25]. Histopathological features in lymph nodes consistent with CSD include granuloma formation, stellate abscesses, and lymphocytic infiltrates. Warthin-Starry silver staining of tissue samples identifies the characteristic dark-staining masses of small curved bacteria. Treatment in immunocompromised patients with doxycycline or daily macrolide is generally for at least 3 months [26]. Our patient, with advanced immunosuppression, presented with extensive generalized lymphadenopathy, raising the possibility of lymphoproliferative disorders, fungal infections, and tuberculosis in the differential diagnosis. She had no skin lesions, subcutaneous masses, or involvement of liver and spleen on CT scans, as might be expected in HIV-infected patients with Bartonella infection. One year prior to presentation, she had a lymph node biopsy that revealed necrotizing granuloma with negative fungal and mycobacterial stains and no evidence for lymphoproliferative disorders. A diagnosis of CSD was not made at that time as Warthin-Starry stain and Bartonella PCR were not performed. Warthin-Starry stains are not routinely performed on histologic specimens unless specifically asked for by clinicians. Our patient’s clinical presentation with prolonged generalized lymphadenopathy of over 1-year duration, neither typical of self-limited CSD nor of BA and other manifestations described in HIV-infected patients, is likely due to her intermittent adherence to ART and past exposure to macrolide therapy taken for MAC prophylaxis. Warthin-Starry staining on the second lymph node biopsy revealed typical findings on histopathology for CSD, and the patient responded well to azithromycin antibiotic therapy. Conclusions Cat-scratch disease may present with prolonged generalized lymphadenopathy, which is an unusual presentation in HIV patients with advanced immunosuppression. Awareness of the possibility of CSD in a similar clinical scenario may prompt early recognition and management of this disease. Genna Pearl, MD, St. George’s University School of Medicine reviewed and searched the literature. Conflicts of interest None. Figure 1. Chest X-ray at presentation: (A) Frontal view, right hilar (arrow) opacities suggestive of lymphadenopathy; (B) Lateral view, subcarinal (arrow) opacities suggestive of lymphadenopathy. Figure 2. At presentation, contrast-enhanced CT scan of the neck, revealing bilateral cervical lymphadenopathy; the largest node was in the right supraclavicular region (arrow) with central low attenuation relative to periphery with enhancement. Figure 3. At Presentation, selected axial (A, B) and coronal (C) images from contrast-enhanced CT scan of the chest, demonstrating bilateral axillary (thick arrows), subcarinal (long arrows), and right hilar larger than left (short arrows) lymphadenopathy. Figure 4. One week after start of treatment, selected axial (A, B) and coronal (C, D) contrast-enhanced CT scan of the chest, demonstrating significant reduction in size of the right supraclavicular (arrow in C), bilateral axillary, hilar, and subcarinal lymphadenopathy, indicating a favorable response to treatment. Figure 5. One week after start of treatment, Axial contrast-enhanced CT image at level of lower pole of kidneys, demonstrating sub-centimeter and enlarged mesenteric lymph nodes (arrows). ==== Refs References: 1. Ridder GJ Boedeker CC Technau-Ihling K Role of cat-scratch disease lymphadenopathy in the head and neck Clin Infect Dis 2002 35 643 49 12203159 2. Windsor JJ Cat-scratch disease: epidemiology, aetiology and treatment Br J Biomed Sci 2001 58 101 10 11440202 3. Ben-Ami R Ephros M Avidor B Cat-scratch disease in elderly patients Clin Infect Dis 2005 41 969 74 16142661 4. Maman E Bickels J Ephros M Musculoskeletal Manifestations of cat-scratch disease Clin Infect Dis 2007 45 1535 40 18190312 5. Koehler JE Sanchez MA Tye S Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever Clin Infect Dis 2003 37 559 66 12905141 6. Koehler JE Quinn FD Berger TG Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis N Engl J Med 1992 327 1625 31 1435899 7. Cotell SL Noskin GA Bacillary angiomatosis. Clinical and histologic features, diagnosis and treatment Arch Intern Med 1994 154 524 28 8122945 9. Okaro U Addisu A Casanas B Anderson B Bartonella species, an emerging cause of blood-culture-negative endocarditis Clin Microbiol Rev 2017 30 709 49 28490579 9. Relman DA Loutit JS Schmidt TM The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens N Engl J Med 1990 323 1573 80 2233945 10. Regnery RL Olson JG Perkins BA Bibb W Serological response to “Rochalimaea henselae” antigen in suspected cat-scratch disease Lancet 1992 339 1443 45 1351130 11. Szelc-Kelly CM Goral S Perez-Perez Gl Serologic responses to Bartonella and Afipia antigens in patients with cat-scratch disease Pediatrics 1995 96 1137 42 7491236 12. Zangwill KM Hamilton DH Perkins BA Cat-scratch disease in Connecticut. Epidemiology, risk factors and evaluation of a new diagnostic test N Engl J Med 1993 329 8 13 8505963 13. Jacomo V Kelly PJ Raoult D Natural history of Bartonella infections (an exception to Koch’s Postulate) Clin Diagn Lab Immunol 2002 9 8 18 11777823 14. Carithers HA Cat-scratch disease. An overview based on a study of 1,200 patients Am J Dis Child 1985 139 11 1124 33 4061408 15. Lenoir AA Storch GA DeSchryver-Kecskemeti K Granulomatous hepatitis associated with cat-scratch disease Lancet 1988 1 1132 36 2896959 16. Delahoussaye PM Osborne BM Cat-scratch disease presenting as abdominal visceral granulomas J Infect Dis 1990 161 71 78 1688602 17. Fretzayas A Papadopoulos NG Moustaki M Unsuspected extralymphocutaneous dissemination in febrile cat-scratch disease Scand J Infect Dis 2001 33 599 603 11525355 18. Rolain JM Brouqui P Koehler JE Recommendations for treatment of human infections caused by Bartonella species Antimicrob Agents Chemother 2004 48 1921 33 15155180 19. Mohle-Boetani JC Koehler JE Berger TG Bacillary angiomatosis and bacillary peliosis in Patients infected with human immunodeficiency virus: Clinical characteristics in a case-control Study Clin Infect Dis 1996 22 794 800 8722933 20. Perkocha AL Geaghan MS Benedict Y Bacillary peliosis hepatis and HIV infection N Engl J Med 1990 323 1581 86 2233946 21. Le Joncour A Bidegain F Ziol M Hemophagocytic lymphohistiocytosis associated with Bartonella henselae infection in an HIV-infected patient Clin Infect Dis 2016 62 804 6 26646679 22. Poudel A Lew J Slayton W Dharnidharka VR Bartonella henselae infection inducing hemophagocytic lymphohistiocytosis in a kidney transplant recipient Pediatr Transplant 2014 18 E83 87 24829973 23. Tappero JW Perkins BA Wenger JD Berger TG Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus Clin Microbiol Rev 1995 8 440 50 7553576 24. Scott C Azwa A Cohen C Cat Scratch disease: A diagnostic conundrum Int J STD AIDS 2009 20 8 585 86 19625597 25. Vermeulen MJ Diederen BM Verbakel H Peeters MF Low sensitivity of Bartonella henselae PCR in serum samples of patients with cat-scratch disease lymphadenitis J Med Microbiol 2008 57 1049 50 18628513 26. Koehler JE Tappero JW Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus Clin Infect Dis 1993 17 612 24 8268340